Do you want to read an article? Please log in or register.
In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial
Further Publications
Indications
Related content
Gastritis
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Lancet Gastroenterol Hepatol
Gonsalves NP, Dellon ES, Kliewer KL, Shoda T, Yearout R, Aceves SS, Arva NC, Besse JA, Caldwell JM, Chehade M, Coleman A, Collins MH, Anvari S, Falk GW, Gupta SK, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher C, Menard-Katcher P, Peterson KA, Pletneva MA, Spergel AKR, Spergel JM, Vaysman T, Wechsler JB, Wright BL, Yang GY, Zhang X, Zhou M, Bansal A, Raphael BP, Radwan A, Maloney J, Martin A, Deniz Y, Furuta GT, Martin LJ, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Investigators
doi: 10.1016/S2468-1253(26)00116-0
Esophagus Diseases
Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial
Lancet Gastroenterol Hepatol
Takeuchi H, Machida R, Ando M, Tsubosa Y, Kikuchi H, Kawakubo H, Noma K, Ueno M, Tsushima T, Bamba T, Fujita T, Hamai Y, Kakishita T, Daiko H, Koyanagi K, Matsuda S, Kato K, Sasaki K, Kita R, Kitagawa Y, JCOG1409 investigators
doi: 10.1016/S2468-1253(25)00207-9
Gastrointestinal Cancer
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial
Lancet Gastroenterol Hepatol
Tuynman JB, Yao H, Moolenaar LR, Sietses C, Hompes R, Aigner F, Caycedo-Marulanda A, Chen CC, Deeb M, Doornebosch PG, Feng B, Foo CC, Fürst A, Ito M, de Lacy FB, Leão P, Maykel JA, Muratore A, van Oostendorp SE, Park SC, Pędziwiatr M, Ren M, Seitinger G, Stockmann HBAC, Talsma AK, Türler A, Tong W, Wang Q, Xu Q, Zhang H, van Waesberghe JTM, Ali M, Twisk JWR, Zhang Z, de Lacy AM, Hanna GB, Bonjer HJ, COLOR III Study Group
doi: 10.1016/S2468-1253(26)00022-1
Gastrointestinal Cancer
Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial
Lancet Oncol
Sebag-Montefiore D, Adams R, Gollins S, Samuel LM, Glynne-Jones R, Harte R, West N, Quirke P, Sun Myint A, Bach S, Parsons P, Dhadda AS, Brown N, Brown G, Harrison M, Maggs R, Begum R, Chang E, Hackshaw A, Lopes A, ARISTOTLE Trial Management Group and Investigators
doi: 10.1016/S1470-2045(26)00132-4
ColonoscopyGastrointestinal Cancer
Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial
Lancet Gastroenterol Hepatol
Hüneburg R, van Bokhorst QNE, Pellisé M, Balaguer F, Brunori A, Rösch T, Vangala DB, Trung KV, Kandulski A, Houwen BBSL, Beaumont H, Ramsoekh D, Strassburg CP, Bisschops R, Link A, Marwitz T, Rogee J, Beekum KV, Engel C, Dekker E, Nattermann J, CADLY2 investigators
doi: 10.1016/S2468-1253(26)00163-9
ColonoscopyGastrointestinal Cancer
Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial
Lancet
Kaminski MF, Kalager M, Løberg M, Emilsson L, Macios A, Samy F, Shi J, Fielding S, Hernán MA, Garborg K, Rupinski M, Dekker E, Spaander M, Holme Ø, Zauber AG, Pilonis ND, Didkowska J, Spychalski P, Hoff G, Regula J, Adami HO, Bretthauer M, NordICC Study Group*
doi: 10.1016/S0140-6736(26)00508-8
Gastrointestinal Cancer
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
Lancet
Sun HC, Zhu XD, Shen F, Song TQ, Bai XL, Zeng YY, Chen MS, Huang ZY, Cai JQ, Gao J, Kuang M, Li DY, Xing BC, Li XC, Wen TF, Peng T, Wang YD, Liu LX, Huang C, Shi YH, Huang XW, Wang K, Gao Q, Zhou J, Fan J
doi: 10.1016/S0140-6736(26)01252-3
Gallbladder and Biliary Diseases
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Lancet Gastroenterol Hepatol
Hirschfield GM, Bowlus CL, Jones DEJ, Kremer AE, Mayo MJ, Tanaka A, Andreone P, Jia J, Jin Q, Macías-Rodríguez RU, Cobitz AR, Currie BM, Gorey C, Lazic I, Podmore D, Ribeiro A, Shannon JB, Swift B, McLaughlin MM, Levy C, GLISTEN Study Group
doi: 10.1016/S2468-1253(25)00192-X
Gastrointestinal Cancer
Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial
Lancet Gastroenterol Hepatol
Schouten TJ, Prinsze KJ, Henry AC, Daamen LA, Besselink MG, Bonsing BA, Bosscha K, Busch OR, Cirkel GA, van Dam RM, van Eijck CH, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IHJT, Kazemier G, Liem MSL, de Meijer VE, Sven D Mieog J, Patijn GA, Roos D, Schreinemakers JMJ, Stommel MWJ, Wit F, van Werkhoven CH, Molenaar IQ, Smits FJ, van Santvoort HC, Dutch Pancreatic Cancer Group
doi: 10.1016/S2468-1253(25)00367-X